Gleason Group’s CVS Health CVS Stock Holding History

Gleason Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.31K	Hold	62	–	–	﹤0.01%	305
2026 Q2	$6.41K	Buy	+62	New	+$5.53K	﹤0.01%	283
2024 Q3	–	Sell	-147	Closed	-$8.68K	–	210
2024 Q2	$8.68K	Buy	+147	New	+$9.2K	﹤0.01%	199
2023 Q2	–	Sell	-57	Closed	-$4.21K	–	233
2023 Q1	$4.21K	Buy	57 +1	+2%	+$84	﹤0.01%	201
2022 Q4	$5.25K	Hold	56	–	–	﹤0.01%	189
2022 Q3	$5K	Buy	56 +1	+2%	+$99	﹤0.01%	198
2022 Q2	$5K	Hold	55	–	–	﹤0.01%	195
2022 Q1	$6K	Hold	55	–	–	﹤0.01%	180
2021 Q4	$6K	Buy	55 +1	+2%	+$92	﹤0.01%	172
2021 Q3	$5K	Hold	54	–	–	﹤0.01%	180
2021 Q2	$5K	Hold	54	–	–	﹤0.01%	178
2021 Q1	$4K	Buy	54 +1	+2%	+$73	﹤0.01%	175
2020 Q4	$4K	Hold	53	–	–	﹤0.01%	170
2020 Q3	$3K	Buy	53 +1	+2%	+$62	﹤0.01%	164
2020 Q2	$3K	Hold	52	–	–	﹤0.01%	167
2020 Q1	$3K	Buy	+52	New	+$3.47K	﹤0.01%	164

Other funds holding CVS

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Gleason Group's CVS Position: Q3 2026 in Review

Gleason Group held its CVS Health (CVS) position steady in Q3 2026 at 62 shares worth $5.31K. The position accounts for ﹤0.01% of the portfolio, ranked #305.

Gleason Group first reported a position in CVS in Q1 2020 and has held it in 16 quarters since. The position peaked at $8.68K in Q2 2024. 557 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

Gleason Group held 62 shares of CVS Health worth $5.31K as of Q3 2026.
Gleason Group left its CVS Health share count unchanged in Q3 2026.
CVS Health made up ﹤0.01% of Gleason Group's portfolio in Q3 2026, its #305 holding.
Gleason Group first reported a position in CVS Health in Q1 2020 and has held it in 16 quarters since.
Gleason Group's CVS Health position peaked at $8.68K in Q2 2024.
557 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Gleason Group's 13F filing for Q3 2026, filed 15 Oct 2026.